Purification and Properties of an Intranuclear Virus-specific Antigen from Tissue Infected with Borna Disease Virus

References

1. Axen R., Ernback S. 1971; Chemical fixation of enzymes to cyanogen halide activated polysaccharide carriers. European Journal of Biochemistry 18:351–360
   [Google Scholar]
2. Becht H., Malole B. 1975; Comparative evaluation of different fixation procedures and different coupling reagents for the demonstration of influenza virus-specific antibodies by indirect haemagglutination test. Medical Microbiology and Immunology 162:43–53
   [Google Scholar]
3. Danner K. 1976; Labordiagnose der Borna’schen Krankheit. Über den Nachweis von Antikörpern im Zentralnervensystem. Zentralblatt für Veterinärmedizin B23:856–867
   [Google Scholar]
4. Fazekas De St. Groth, S., Scheidegger D. 1980; Production of monoclonal antibodies: strategy and tactics. Journal of Immunological Methods 35:11–20
   [Google Scholar]
5. Herzog S., Rott R. 1980; Replication of Borna disease virus in cell cultures. Medical Microbiology and Immunology 168:153–158
   [Google Scholar]
6. Jensenius J. C., Andersen I., Hau J., Crone M., Koch C. 1981; Eggs: conveniently packaged antibodies. Methods for purification of yolk IgG. Journal of Immunological Methods 46:63–68
   [Google Scholar]
7. Kao M., Ludwig H., Gosztonyi G. 1984; Adaptation of Borna disease virus to the mouse. Journal of General Virology 65:1845–1849
   [Google Scholar]
8. Köhler G., Milstein C. 1975; Continuous cultures of fused cells secreting antibody of predefined specificity. Nature, London 256:495–497
   [Google Scholar]
9. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 227:680–685
   [Google Scholar]
10. Ludwig H., Becht H. 1977; Borna disease-a summary of our present knowledge. In Slow Virus Infections of the Central Nervous System pp. 75–83 Edited by Ter Meulen V. Katz M. New York, Heidelberg & Berlin: Springer-Verlag;
    [Google Scholar]
11. Ludwig H., Becht H., Groh L. 1973; Borna disease (BD), a slow virus infection: biological properties of the virus. Medical Microbiology and Immunology 158:275–289
    [Google Scholar]
12. Maher P., Molday R. S. 1977; Binding of concanavalin A to Ricinus communis agglutinin and its application in cell-surface labeling studies. FEBS Letters 84:391–395
    [Google Scholar]
13. Narayan O., Herzog S., Frese K., Scheefers H., Rott R. 1983; Behavioral disease in rats caused by immunopathological responses to persistent Borna virus in the brain. Science 220:1401–1403
    [Google Scholar]
14. Porath J., Sundberg L. 1972; High capacity chemoabsorbents for protein immobilisation. Nature New Biology 238:261–262
    [Google Scholar]
15. Talbot P. J., Knobler R. L., Buchmeier M. J. 1984; Western and dot immunoblotting analysis of viral antigens and antibodies: application to murine hepatitis virus. Journal of Immunological Methods 73:177–188
    [Google Scholar]
16. Towbin H., Staehelin T., Cordon J. 1979; Electrophoretic transfer of proteins from polyacrylamide gel to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences, U.S.A. 76:4350–4354
    [Google Scholar]
17. Von Sprockhoff H. 1954; Untersuchungen über die Komplement-Bindungsreaktion bei der Borna’ schen Krankheit. Zentralblatt fur Veterinarmedizin 1:494–530
    [Google Scholar]
18. Wagner K., Ludwig H., Paulsen J. 1968; Fluoreszenzserologischer Nachweis von Borna-Virus Antigen. Berliner und Münchener tierärztliche Wochenschrift 81:395–396
    [Google Scholar]